Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Synthetic Biologics, Inc.

TRADE

AMEX: SYNHealthcare / Biotechnology / USA
0.92+0.04+4.55%Vol 789 3251Y Perf -97.06%
Oct 16th, 2018 16:00
BID0.89 ASK0.92
Open0.90 Previous Close0.88
Pre-Market0.87 After-Trading0.92
 -0.01 -1.14%  - -%
Target Price
38.00 
Analyst Rating
Strong Buy 1.00
Potencial %
4 030.43 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)7 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
0.25 
Earnings Date
7th Nov 2018

Today's Price Range

0.860.93

 

52wk Range

0.8433.25

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
-55.34%
3 Months
338.10%
6 Months
155.56%
1 Year
-97.06%
3 Years
-61.34%
5 Years
-42.14%

Quotes

Name / TickerPriceChg.Chg.%
SYN0.920.04004.55
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.70
Current Ratio 1.80
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 2.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 21.96
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -0.50
Cash Flow Per Share -5.06
Price to Tangible Book-1.01
Book Value per Share-0.90
Enterprise Value (in ths.)-585
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-263.46
ROE last 12 Months 2 800.71
Return on Assets (5Y Avg) -209.59
ROA last 12 Months -176.78
Return on Capital (5Y Avg) -549.91
ROC last 12 Months -115.04
Return on invested Capital Q -115.04
Return on invested Capital Y-1 886.50
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-1.40-1.0525.00
Q01 2018-1.75-0.7060.00
Q04 2017-1.750.70140.00
Q03 2017-1.75-4.90-180.00
Q02 2017-2.45-1.0557.14
Q01 2017-0.07-0.0271.43
Q04 2016-0.09-0.0277.78
Q03 2016-0.09-0.090.00
Earnings Per EndEstimateRevision %Trend
9/2018 QR-1.325.71Positive
12/2018 QR-1.280.00-
12/2018 FY-4.398.16Positive
12/2019 FY0.32130.48Positive
Next Report Date7th Nov 2018
Estimated EPS Next Report-1.32
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume789 325
Shares Outstanding (in ths.)7 210
Trades Count1 915
Dollar Volume688 245
Avg. Volume310 391
Avg. Weekly Volume2 131 379
Avg. Monthly Volume2 736 670
Avg. Quarterly Volume910 515

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

70%30%

Bearish Bullish

51%49%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Moderate Buy
1.67

There are no comments yet.

News

x